Drug:
Reaction: INJECTION SITE ERYTHEMA
20260101 - 20261231
No. 1 - 100
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1 | 26555433 |
US |
83 | 2 |
Wrong technique in product usage process, Injection site erythema, |
||||
EVOLOCUMAB, |
||||
| 2 | 26555605 |
US |
46 | 2 |
Erythema, Dyspnoea, Pruritus, Injection site pruritus, Injection site erythema, |
||||
TIRZEPATIDE, |
||||
| 3 | 26555775 |
US |
||
Injection site erythema, Injection site bruising, |
||||
RISPERIDONE, |
||||
| 4 | 26556312 |
US |
55 | |
Injection site pruritus, Injection site urticaria, Injection site erythema, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 5 | 26556393 |
JP |
1 | |
Sputum retention, Injection site erythema, Injection site induration, COVID-19, Insomnia, Pneumonia, Restlessness, Pneumonia, Epilepsy, |
||||
LEUPROLIDE ACETATE, CELECOXIB, LANSOPRAZOLE, MAGNESIUM OXIDE, PIPERACILLIN SODIUM,TAZOBACTAM SODIUM, PIPERACILLIN SODIUM,TAZOBACTAM SODIUM, LEVETIRACETAM, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, QUETIAPINE FUMARATE, QUETIAPINE, CEFAZOLIN SODIUM, REMDESIVIR, REMDESIVIR, |
||||
| 6 | 26557216 |
US |
60 | 2 |
Injection site erythema, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 7 | 26557401 |
US |
49 | 2 |
Injection site swelling, Injection site erythema, Injection site pruritus, |
||||
DUPILUMAB, |
||||
| 8 | 26557537 |
US |
81 | 2 |
Injection site erythema, Injection site erythema, Injection site erythema, |
||||
ALIROCUMAB, |
||||
| 9 | 26557601 |
US |
2 | |
Injection site erythema, |
||||
DUPILUMAB, |
||||
| 10 | 26557636 |
US |
38 | 1 |
Injection site swelling, Injection site erythema, Injection site pruritus, Sinus operation, |
||||
DUPILUMAB, DUPILUMAB, OMALIZUMAB, |
||||
| 11 | 26557819 |
US |
62 | |
Loss of consciousness, Heart rate decreased, Blood glucose decreased, Injection site discolouration, Throat tightness, Eye swelling, Injection site swelling, Injection site erythema, Injection site pruritus, Dyspnoea, Injection site pain, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 12 | 26557825 |
US |
||
Injection site rash, Injection site erythema, Injection site swelling, Herpes zoster, Arthralgia, Swelling, White blood cell count increased, Pain, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 13 | 26558094 |
US |
61 | 2 |
Injection site pruritus, Injection site erythema, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 14 | 26558269 |
US |
44 | |
Injection site erythema, Injection site pruritus, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 15 | 26558287 |
US |
64 | |
Injection site erythema, Injection site pruritus, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 16 | 26558416 |
US |
62 | 1 |
Injection site erythema, Injection site induration, |
||||
TIRZEPATIDE, |
||||
| 17 | 26559165 |
61 | 2 | |
Injection site erythema, Injection site rash, Injection site urticaria, Injection site pain, Injection site pruritus, Injection site mass, |
||||
REPOSITORY CORTICOTROPIN, |
||||
| 18 | 26559200 |
48 | 2 | |
Injection site swelling, Injection site erythema, Injection site pain, |
||||
| 19 | 26560313 |
27 | ||
Injection site swelling, Injection site erythema, Injection site pruritus, |
||||
BIMEKIZUMAB, NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE, MELOXICAM, METHOCARBAMOL, METHOCARBAMOL TABLETS, |
||||
| 20 | 26560317 |
US |
18 | 2 |
Injection site urticaria, Idiopathic urticaria, Injection site erythema, Injection site swelling, |
||||
DUPILUMAB, |
||||
| 21 | 26560355 |
US |
45 | 2 |
Eczema, Injection site irritation, Injection site erythema, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 22 | 26560465 |
US |
2 | |
Injection site erythema, Injection site swelling, |
||||
DUPILUMAB, |
||||
| 23 | 26561528 |
US |
||
Injection site erythema, Injection site pruritus, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 24 | 26550585 |
US |
||
Injection site erythema, Injection site pruritus, Injection site irritation, |
||||
TIRZEPATIDE, |
||||
| 25 | 26550816 |
US |
||
Injection site erythema, |
||||
TIRZEPATIDE, |
||||
| 26 | 26550870 |
US |
46 | 2 |
Injection site erythema, |
||||
TIRZEPATIDE, |
||||
| 27 | 26551335 |
US |
64 | 1 |
Injection site erythema, Injection site pruritus, |
||||
PLOZASIRAN, PLOZASIRAN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, INSULIN GLARGINE, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, FENOFIBRATE, TIRZEPATIDE, INSULIN ASPART, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, PRAMIPEXOLE, PREGABALIN, ROSUVASTATIN, TORSEMIDE, VALSARTAN, VALSARTAN ORAL, ICOSAPENT ETHYL, DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE, |
||||
| 28 | 26551360 |
US |
69 | 2 |
Injection site irritation, Injection site erythema, |
||||
TIRZEPATIDE, |
||||
| 29 | 26551931 |
US |
56 | 2 |
Incorrect dose administered, Injection site erythema, |
||||
TIRZEPATIDE, |
||||
| 30 | 26552046 |
US |
71 | 2 |
Injection site pain, Injection site erythema, Injection site pruritus, |
||||
TIRZEPATIDE, |
||||
| 31 | 26552180 |
US |
66 | 2 |
Feeling hot, Erythema, Facial pain, Swelling face, Injection site erythema, Injection site pruritus, |
||||
TIRZEPATIDE, |
||||
| 32 | 26552286 |
US |
27 | 2 |
Injection site erythema, |
||||
FREMANEZUMAB-VFRM, FREMANEZUMAB-VFRM, |
||||
| 33 | 26553155 |
US |
||
Injection site pruritus, Injection site erythema, Injection site pain, Injection site swelling, |
||||
DEGARELIX, |
||||
| 34 | 26553243 |
US |
||
Injection site erythema, Injection site rash, Injection site pain, Injection site warmth, Incorrect route of product administration, |
||||
DEGARELIX, |
||||
| 35 | 26553261 |
US |
66 | 2 |
Injection site erythema, Injection site pain, Product preparation error, |
||||
TRALOKINUMAB-LDRM, |
||||
| 36 | 26553487 |
US |
17 | 1 |
Chills, Tremor, Pyrexia, Injection site erythema, Off label use, |
||||
PEGVALIASE-PQPZ, PEGVALIASE-PQPZ, |
||||
| 37 | 26553693 |
US |
46 | 2 |
Injection site reaction, Injection site erythema, Injection site swelling, Injection site pruritus, Injection site mass, Application site bruise, Injection site pain, |
||||
PEGVALIASE-PQPZ, PEGVALIASE-PQPZ, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, FAMOTIDINE, TOPIRAMATE, TOPIRAMATE SPINKLE, ARIPIPRAZOLE, CLONIDINE, DULOXETINE HYDROCHLORIDE, DULOXETINE, FOLIC ACID, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, SULFASALAZINE, ERGOCALCIFEROL, |
||||
| 38 | 26554199 |
1 | ||
Migraine, Alcohol use, Injection site erythema, Injection site mass, |
||||
NALTREXONE, NALTREXONE, GABAPENTIN, CYCLOBENZAPRINE, NALTREXONE, LAMOTRIGINE, |
||||
| 39 | 26554451 |
US |
61 | 1 |
Scoliosis, Loss of consciousness, Visual impairment, Eye pain, Overdose, Inappropriate schedule of product administration, Weight increased, Procedural pain, Injection site erythema, Injection site bruising, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 40 | 26554898 |
US |
67 | 1 |
Decreased appetite, Flatulence, Nausea, Injection site erythema, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 41 | 26548911 |
US |
51 | 2 |
Injection site erythema, |
||||
TIRZEPATIDE, |
||||
| 42 | 26548968 |
US |
||
Injection site erythema, |
||||
TIRZEPATIDE, |
||||
| 43 | 26548985 |
US |
||
Injection site pain, Injection site erythema, |
||||
TIRZEPATIDE, |
||||
| 44 | 26549030 |
US |
2 | |
Injection site erythema, Injection site pain, |
||||
TERIPARATIDE, |
||||
| 45 | 26549139 |
US |
2 | |
Injection site reaction, Injection site erythema, Injection site swelling, |
||||
DUPILUMAB, |
||||
| 46 | 26549162 |
US |
1 | |
Injection site pain, Injection site erythema, |
||||
DUPILUMAB, |
||||
| 47 | 26549207 |
US |
48 | 1 |
Injection site erythema, |
||||
DUPILUMAB, |
||||
| 48 | 26549352 |
US |
29 | 2 |
Injection site erythema, Injection site pain, Muscle tightness, Anxiety, Musculoskeletal stiffness, Erythema, Dermatitis atopic, Pruritus, Swelling, Dry skin, Wound, |
||||
DUPILUMAB, |
||||
| 49 | 26549385 |
US |
35 | 1 |
Injection site erythema, |
||||
DUPILUMAB, |
||||
| 50 | 26549511 |
US |
60 | 2 |
Injection site erythema, |
||||
DUPILUMAB, |
||||
| 51 | 26549582 |
US |
13 | 1 |
Injection site erythema, Injection site swelling, |
||||
DUPILUMAB, |
||||
| 52 | 26549616 |
US |
43 | 2 |
Retching, Food refusal, Dysphagia, Injection site urticaria, Pruritus, Injection site erythema, Product dose omission in error, |
||||
DUPILUMAB, |
||||
| 53 | 26549642 |
US |
78 | 2 |
Injection site inflammation, Injection site pain, Injection site erythema, Nausea, Headache, Eructation, Diarrhoea, Fatigue, Myalgia, Arthralgia, Incorrect dose administered, Off label use, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 54 | 26549664 |
US |
40 | 2 |
Dermatitis atopic, Injection site erythema, Injection site pain, |
||||
DUPILUMAB, |
||||
| 55 | 26549758 |
US |
65 | 2 |
Injection site erythema, |
||||
TERIPARATIDE, |
||||
| 56 | 26546893 |
US |
80 | 2 |
Dry mouth, Pollakiuria, Rhinorrhoea, Chromaturia, Injection site mass, Injection site pain, Injection site erythema, |
||||
SARILUMAB, |
||||
| 57 | 26547335 |
US |
15 | 2 |
Injection site pain, Injection site erythema, |
||||
DUPILUMAB, |
||||
| 58 | 26547400 |
US |
2 | |
Injection site erythema, |
||||
DUPILUMAB, |
||||
| 59 | 26547408 |
US |
1 | |
Injection site erythema, Injection site swelling, |
||||
DUPILUMAB, |
||||
| 60 | 26547430 |
|||
Injection site rash, Injection site erythema, Injection site pruritus, Injection site pain, |
||||
BIMEKIZUMAB, |
||||
| 61 | 26547463 |
US |
11 | 1 |
Injection site erythema, Injection site swelling, |
||||
DUPILUMAB, |
||||
| 62 | 26547583 |
US |
61 | 2 |
Injection site erythema, Injection site bruising, |
||||
DUPILUMAB, |
||||
| 63 | 26547642 |
US |
28 | 2 |
Injection site irritation, Injection site erythema, Injection site swelling, Injection site rash, |
||||
DUPILUMAB, |
||||
| 64 | 26547741 |
US |
67 | 1 |
Injection site erythema, |
||||
DUPILUMAB, |
||||
| 65 | 26548035 |
|||
Injection site erythema, |
||||
CERTOLIZUMAB PEGOL, UPADACITINIB, |
||||
| 66 | 26548188 |
US |
2 | |
Injection site inflammation, Injection site erythema, |
||||
DUPILUMAB, |
||||
| 67 | 26548421 |
US |
17 | 2 |
Injection site swelling, Injection site pruritus, Injection site erythema, Injection site warmth, |
||||
DUPILUMAB, |
||||
| 68 | 26548426 |
US |
50 | 2 |
Injection site erythema, Injection site swelling, Injection site pain, |
||||
DUPILUMAB, |
||||
| 69 | 26548471 |
US |
25 | 2 |
Injection site erythema, Injection site pain, Injection site discolouration, Pruritus, |
||||
DUPILUMAB, METOPROLOL TARTRATE, METOPROLOL, |
||||
| 70 | 26548503 |
CA |
28 | 2 |
Psoriatic arthropathy, Injection site warmth, Injection site pruritus, Injection site erythema, |
||||
ADALIMUMAB-RYVK, |
||||
| 71 | 26548586 |
US |
2 | |
Rash macular, Dry skin, Weight decreased, Cough, Skin exfoliation, Injection site erythema, |
||||
DUPILUMAB, BECLOMETHASONE DIPROPIONATE HFA, TIOTROPIUM BROMIDE AND OLODATEROL, ALBUTEROL SULFATE, ALBUTEROL, ALENDRONATE SODIUM, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, MONTELUKAST, TIRZEPATIDE, ROSUVASTATIN, TRIAMTERENE CAPSULES, TRIAMTERENE, ERGOCALCIFEROL, |
||||
| 72 | 26548677 |
US |
53 | 2 |
Injection site irritation, Injection site pruritus, Injection site erythema, |
||||
SARILUMAB, |
||||
| 73 | 26548710 |
US |
54 | 2 |
Nasopharyngitis, Condition aggravated, Rhinorrhoea, Respiratory tract congestion, Injection site urticaria, Injection site erythema, Injection site swelling, Injection site warmth, Product use in unapproved indication, |
||||
DUPILUMAB, CALCIUM, CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE, RALOXIFENE HYDROCHLORIDE, HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE, HYDROXYZINE HYDROCHLORIDE ORAL, LINACLOTIDE, MAGNESIUM, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, FAMOTIDINE, METOCLOPRAMIDE HYDROCHLORIDE, SPIRONOLACTONE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ERGOCALCIFEROL, BUPROPION HYDROCHLORIDE, ALPRAZOLAM, |
||||
| 74 | 26552659 |
36 | 2 | |
Upper limb fracture, Psoriasis, Condition aggravated, Stress, Pustule, Injection site swelling, Injection site erythema, |
||||
GUSELKUMAB, |
||||
| 75 | 26542191 |
CA |
2 | |
Psoriatic arthropathy, Therapeutic product effect decreased, Injection site pruritus, Injection site erythema, Injection site swelling, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, CERTOLIZUMAB PEGOL, |
||||
| 76 | 26542355 |
US |
53 | 2 |
Injection site pruritus, Injection site erythema, |
||||
TIRZEPATIDE, |
||||
| 77 | 26542466 |
US |
2 | |
Injection site mass, Injection site swelling, Injection site erythema, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 78 | 26543641 |
US |
2 | |
Rash, Injection site erythema, Injection site pain, |
||||
GLATIRAMER ACETATE, GLATIRAMER ACETATE, |
||||
| 79 | 26543880 |
US |
2 | |
Injection site pruritus, Injection site erythema, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 80 | 26544041 |
GB |
7 | 2 |
Swollen tongue, Paraesthesia, Anxiety, Tachypnoea, Dry mouth, Back pain, Anaphylactic reaction, Muscle spasms, Pain, Injection site erythema, |
||||
ABALOPARATIDE, |
||||
| 81 | 26544239 |
US |
71 | |
Injection site pruritus, Injection site erythema, Injection site discolouration, |
||||
TIRZEPATIDE, |
||||
| 82 | 26544345 |
US |
1 | |
Injection site erythema, Disease progression, |
||||
OCRELIZUMAB AND HYALURONIDASE, OCRELIZUMAB, |
||||
| 83 | 26544399 |
BR |
2 | |
Lymphoma, Lung neoplasm, Decreased immune responsiveness, Injection site erythema, |
||||
| 84 | 26544744 |
US |
2 | |
Injection site erythema, Injection site urticaria, Device issue, |
||||
RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, |
||||
| 85 | 26544911 |
EU |
45 | 2 |
Polyneuropathy, Injection site erythema, Arthralgia, Myalgia, |
||||
PEGINTERFERON ALFA-2A, |
||||
| 86 | 26545532 |
US |
46 | 2 |
Memory impairment, Nausea, Diarrhoea, Abdominal discomfort, Injection site pain, Injection site erythema, Hunger, Binge eating, Drug ineffective, Food craving, Product dose omission issue, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 87 | 26546016 |
US |
45 | 2 |
Injection site pruritus, Injection site erythema, Injection site pain, |
||||
DUPILUMAB, |
||||
| 88 | 26546622 |
US |
28 | 2 |
Injection site mass, Injection site erythema, Injection site pruritus, |
||||
PEGVALIASE-PQPZ, PEGVALIASE-PQPZ, CETIRIZINE HYDROCHLORIDE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ATOMOXETINE HYDROCHLORIDE, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE, CETIRIZINE HCL, CETIRIZINE, ERGOCALCIFEROL, |
||||
| 89 | 26546677 |
US |
2 | |
Injection site erythema, |
||||
PEGVALIASE-PQPZ, PEGVALIASE-PQPZ, |
||||
| 90 | 26535979 |
US |
45 | 2 |
Panic attack, Vomiting, Injection site rash, Injection site pain, Injection site pruritus, Nausea, Injection site erythema, Injection site irritation, Asthenia, |
||||
TIRZEPATIDE, ALPRAZOLAM, ALPRAZOLAM, ESCITALOPRAM, |
||||
| 91 | 26536424 |
US |
72 | 2 |
Product dose omission issue, Injection site haemorrhage, Injection site erythema, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 92 | 26536477 |
US |
74 | 2 |
Injection site erythema, Injection site pruritus, |
||||
TIRZEPATIDE, TIRZEPATIDE, MONTELUKAST, METOPROLOL TARTRATE, METOPROLOL, GABAPENTIN, OXYCODONE, FUROSEMIDE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ROSUVASTATIN, ERGOCALCIFEROL, |
||||
| 93 | 26536620 |
CA |
46 | 1 |
Hypoglycaemia, Chills, Diarrhoea, Diverticulitis, Dysgeusia, Fatigue, Headache, Influenza, Nausea, Vomiting, Weight decreased, Injection site erythema, Injection site pruritus, Injection site rash, Therapy partial responder, Intentional dose omission, Inappropriate schedule of product administration, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, HYDROXYCHLOROQUINE SULFATE, CLONAZEPAM, DICLOFENAC, DICLOFENAC SODIUM, ESCITALOPRAM OXALATE, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITALOPRAM, METHOTREXATE, METHOTREXATE SODIUM, FOLIC ACID, SEMAGLUTIDE, SEMAGLUTIDE, ERGOCALCIFEROL, |
||||
| 94 | 26536780 |
US |
72 | 2 |
Injection site erythema, Injection site pruritus, Injection site pain, Injection site swelling, |
||||
TIRZEPATIDE, |
||||
| 95 | 26536857 |
US |
63 | 2 |
Salivary hypersecretion, Constipation, Injection site erythema, Injection site swelling, Injection site pruritus, Injection site rash, |
||||
TIRZEPATIDE, |
||||
| 96 | 26537004 |
US |
67 | |
Injection site urticaria, Injection site erythema, Nausea, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 97 | 26537732 |
US |
75 | 2 |
Injection site erythema, Injection site pruritus, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 98 | 26537900 |
US |
73 | 2 |
Somnolence, Pain, Pyrexia, Influenza like illness, Injection site erythema, Asthma, |
||||
DUPILUMAB, EMPAGLIFLOZIN, MONTELUKAST SODIUM, MONTELUKAST, MIRABEGRON, SERTRALINE HYDROCHLORIDE, SPIRONOLACTONE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, CARVEDILOL, CLONIDINE HYDROCHLORIDE, VALSARTAN, VALSARTAN ORAL, AMITRIPTYLINE HYDROCHLORIDE, AMLODIPINE BESYLATE, FUROSEMIDE, TIRZEPATIDE, INSULIN GLARGINE, CETIRIZINE HYDROCHLORIDE, MELATONIN, ALBUTEROL SULFATE, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, ALBUTEROL SULFATE, TIRZEPATIDE, VALSARTAN, VALSARTAN ORAL, AMLODIPINE BESYLATE, SERTRALINE HYDROCHLORIDE, DICYCLOMINE HYDROCHLORIDE, |
||||
| 99 | 26538088 |
US |
18 | 1 |
Injection site erythema, Injection site swelling, |
||||
DUPILUMAB, CRISABOROLE, |
||||
| 100 | 26538109 |
US |
62 | 2 |
Diarrhoea, Myalgia, Injection site erythema, |
||||
SARILUMAB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-04-28